(Q44361000)

2 December 2017

title

Molecular weight distribution changes during degradation and release of PLGA nanoparticles containing epirubicin HCl. (English)

1 reference

2 December 2017

0 references

Duane T Birnbaum

1

1 reference

2 December 2017

Lisa Brannon-Peppas

series ordinal

2

1 reference

2 December 2017

publication date

1 January 2003

1 reference

Journal of Biomaterials Science. Polymer Edition

2 December 2017

published in

1 reference

2 December 2017

volume

14

1 reference

2 December 2017

issue

1

1 reference

2 December 2017

page(s)

87-102

1 reference

The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1163%2F15685620360511155

Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1163%2F15685620360511155

Influence of particle size and dissolution conditions on the degradation properties of polylactide-co-glycolide particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1163%2F15685620360511155

Visual evidence of acidic environment within degrading poly(lactic-co-glycolic acid) (PLGA) microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1163%2F15685620360511155

Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method.

21 January 2018

1 reference

https://api.crossref.org/works/10.1163%2F15685620360511155

Influence of the preparation methods on the drug release behaviour of loperamide-loaded nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1163%2F15685620360511155

Lidocaine loaded biodegradable nanospheres. II. Modelling of drug release

21 January 2018

1 reference

https://api.crossref.org/works/10.1163%2F15685620360511155

Lidocaine-loaded biodegradable nanospheres. I. Optimization Of the drug incorporation into the polymer matrix.

21 January 2018

1 reference

https://api.crossref.org/works/10.1163%2F15685620360511155

The preparation of sub-200 nm poly(lactide-co-glycolide) microspheres for site-specific drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1163%2F15685620360511155

Influence of poly(DL-lactide) nanocapsules on the biliary clearance and enterohepatic circulation of indomethacin in the rabbit

21 January 2018

1 reference

https://api.crossref.org/works/10.1163%2F15685620360511155

Factors affecting the degradation rate of poly(lactide-co-glycolide) microspheres in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1163%2F15685620360511155

Stability study of nanoparticles of poly(epsilon-caprolactone), poly(D,L-lactide) and poly(D,L-lactide-co-glycolide)

21 January 2018

1 reference

https://api.crossref.org/works/10.1163%2F15685620360511155

10.1163/15685620360511155

21 January 2018

Identifiers

DOI

1 reference

2 December 2017

1 reference